Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Cash & Current Investments: 2012-2024

Historic Cash & Current Investments for CorMedix (CRMD) over the last 12 years, with Dec 2024 value amounting to $51.7 million.

  • CorMedix's Cash & Current Investments rose 22.93% to $56.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $376.5 million, marking a year-over-year increase of 59.00%. This contributed to the annual value of $51.7 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, CorMedix's Cash & Current Investments is $51.7 million, which was down 12.08% from $58.8 million recorded in FY2022.
  • In the past 5 years, CorMedix's Cash & Current Investments ranged from a high of $65.5 million in FY2021 and a low of $46.3 million during FY2020.
  • Moreover, its 2-year median value for Cash & Current Investments was $55.2 million (2022), whereas its average is $55.2 million.
  • As far as peak fluctuations go, CorMedix's Cash & Current Investments spiked by 63.58% in 2020, and later decreased by 10.19% in 2022.
  • Over the past 4 years, CorMedix's Cash & Current Investments (Yearly) stood at $46.3 million in 2020, then soared by 41.24% to $65.5 million in 2021, then dropped by 10.19% to $58.8 million in 2022, then reached $51.7 million in 2024.